RNA
Atrium Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$194.71M
P/E Ratio
—
EPS
$-4.48
Beta
0.93
52W High
$16.77
52W Low
$11.95
50-Day MA
$13.87
200-Day MA
$13.87
Dividend Yield
—
Profit Margin
-265.90%
Forward P/E
—
PEG Ratio
0.00
About Atrium Therapeutics, Inc. Common Stock
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | $18.62M |
| Gross Profit (TTM) | $-25.65M |
| EBITDA | $-49.31M |
| Operating Margin | -3388.00% |
| Return on Equity | -44.00% |
| Return on Assets | -399.30% |
| Revenue/Share (TTM) | $1.20 |
| Book Value | $-4.04 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 10.46 |
| EV/Revenue | 491.01 |
| EV/EBITDA | -5.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -71.10% |
| Shares Outstanding | $15.52M |
| Float | $15.04M |
| % Insiders | 4.26% |
| % Institutions | 20.97% |
Data last updated: 4/29/2026